Generic Name and Formulations:
Serum-derived bovine immunoglobulin/protein isolate (SBI) 5g, dextrose 5g, sunflower lecithin (trace amounts); pwd; per packet; lactose-, gluten-, dye-, and soy-free.
Entera Health, Inc.
Indications for ENTERAGAM:
Clinical dietary management in patients with: limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients, or specific intestinal disorders (eg, irritable bowel syndrome with diarrhea [IBS-D], inflammatory bowel disease [IBD], and HIV-associated enteropathy).
Dissolve packet contents in at least 4oz (120mL) of water or other liquids; stir until fully mixed (do not shake); or, may be mixed in foods (eg, pudding, yogurt); consume dose immediately after mixing. Initially 1 packet twice daily for 2–4 weeks; may increase up to 4 packets daily. Maintenance: at least 1 packet daily.
<2yrs: see full labeling. ≥2yrs: Initially ½ packet daily; may increase dose based on response and tolerance.
Must use under physician supervision. Pregnancy, labor & delivery, nursing mothers: see full labeling.
Mild nausea, constipation, stomach cramps, headache, increased urination.
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D